ABBOTT LABORATORIES (ABL.DE) Stock Fundamental Analysis
Europe - FRA:ABL - US0028241000 - Common Stock
109.02 EUR
+1.6 (+1.49%)
ABL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 60 industry peers in the Health Care Equipment & Supplies industry. ABL has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ABL has a correct valuation and a medium growth rate. With these ratings, ABL could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year ABL was profitable.
ABL had a positive operating cash flow in the past year.
In the past 5 years ABL has always been profitable.
Each year in the past 5 years ABL had a positive operating cash flow.
1.2 Ratios
The Return On Assets of ABL (16.64%) is better than 93.33% of its industry peers.
Looking at the Return On Equity, with a value of 27.65%, ABL belongs to the top of the industry, outperforming 95.00% of the companies in the same industry.
With a decent Return On Invested Capital value of 9.43%, ABL is doing good in the industry, outperforming 80.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ABL is in line with the industry average of 9.00%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.64% | ||
| ROE | 27.65% | ||
| ROIC | 9.43% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
1.3 Margins
ABL's Profit Margin of 32.43% is amongst the best of the industry. ABL outperforms 98.33% of its industry peers.
In the last couple of years the Profit Margin of ABL has grown nicely.
ABL has a Operating Margin of 17.97%. This is amongst the best in the industry. ABL outperforms 81.67% of its industry peers.
In the last couple of years the Operating Margin of ABL has grown nicely.
ABL has a Gross Margin of 56.33%. This is comparable to the rest of the industry: ABL outperforms 53.33% of its industry peers.
ABL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.97% | ||
| PM (TTM) | 32.43% | ||
| GM | 56.33% |
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ABL is still creating some value.
The number of shares outstanding for ABL remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ABL has less shares outstanding
Compared to 1 year ago, ABL has an improved debt to assets ratio.
2.2 Solvency
ABL has an Altman-Z score of 5.65. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 5.65, ABL belongs to the best of the industry, outperforming 88.33% of the companies in the same industry.
ABL has a debt to FCF ratio of 1.98. This is a very positive value and a sign of high solvency as it would only need 1.98 years to pay back of all of its debts.
ABL's Debt to FCF ratio of 1.98 is fine compared to the rest of the industry. ABL outperforms 80.00% of its industry peers.
ABL has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
ABL has a Debt to Equity ratio (0.26) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.98 | ||
| Altman-Z | 5.65 |
ROIC/WACC1.12
WACC8.39%
2.3 Liquidity
A Current Ratio of 1.82 indicates that ABL should not have too much problems paying its short term obligations.
ABL has a Current ratio of 1.82. This is comparable to the rest of the industry: ABL outperforms 56.67% of its industry peers.
A Quick Ratio of 1.30 indicates that ABL should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.30, ABL is doing good in the industry, outperforming 61.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 10.40% over the past year.
Measured over the past 5 years, ABL shows a small growth in Earnings Per Share. The EPS has been growing by 7.59% on average per year.
Looking at the last year, ABL shows a small growth in Revenue. The Revenue has grown by 6.37% in the last year.
ABL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.63% yearly.
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%
3.2 Future
ABL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.87% yearly.
Based on estimates for the next years, ABL will show a small growth in Revenue. The Revenue will grow by 7.13% on average per year.
EPS Next Y11.44%
EPS Next 2Y10.84%
EPS Next 3Y10.85%
EPS Next 5Y9.87%
Revenue Next Year6.43%
Revenue Next 2Y7.1%
Revenue Next 3Y7.23%
Revenue Next 5Y7.13%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
ABL is valuated quite expensively with a Price/Earnings ratio of 25.18.
66.67% of the companies in the same industry are more expensive than ABL, based on the Price/Earnings ratio.
ABL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.83, which is the current average of the S&P500 Index.
ABL is valuated rather expensively with a Price/Forward Earnings ratio of 21.91.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ABL is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of ABL to the average of the S&P500 Index (32.68), we can say ABL is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.18 | ||
| Fwd PE | 21.91 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as ABL.
ABL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ABL is cheaper than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 32.3 | ||
| EV/EBITDA | 20.34 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ABL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.2
PEG (5Y)3.32
EPS Next 2Y10.84%
EPS Next 3Y10.85%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.89%, ABL has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.13, ABL pays a bit more dividend than its industry peers.
ABL's Dividend Yield is slightly below the S&P500 average, which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.89% |
5.2 History
The dividend of ABL is nicely growing with an annual growth rate of 11.40%!
Dividend Growth(5Y)11.4%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
28.42% of the earnings are spent on dividend by ABL. This is a low number and sustainable payout ratio.
ABL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.42%
EPS Next 2Y10.84%
EPS Next 3Y10.85%
FRA:ABL (11/7/2025, 7:00:00 PM)
109.02
+1.6 (+1.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners80.68%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap189.74B
Revenue(TTM)43.84B
Net Income(TTM)13.98B
Analysts78.86
Price Target126.54 (16.07%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.89% |
Yearly Dividend1.92
Dividend Growth(5Y)11.4%
DP28.42%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.08%
Min EPS beat(2)-0.58%
Max EPS beat(2)0.73%
EPS beat(4)1
Avg EPS beat(4)-0.34%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)4
Avg EPS beat(8)0.55%
EPS beat(12)8
Avg EPS beat(12)3.44%
EPS beat(16)12
Avg EPS beat(16)8.67%
Revenue beat(2)0
Avg Revenue beat(2)-0.85%
Min Revenue beat(2)-1.37%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-0.81%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.19%
Revenue beat(8)1
Avg Revenue beat(8)-0.29%
Revenue beat(12)5
Avg Revenue beat(12)0.8%
Revenue beat(16)9
Avg Revenue beat(16)2.75%
PT rev (1m)2.57%
PT rev (3m)0.93%
EPS NQ rev (1m)0.03%
EPS NQ rev (3m)0.07%
EPS NY rev (1m)0.15%
EPS NY rev (3m)-0.15%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-0.01%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.18 | ||
| Fwd PE | 21.91 | ||
| P/S | 5.08 | ||
| P/FCF | 32.3 | ||
| P/OCF | 24.22 | ||
| P/B | 4.33 | ||
| P/tB | 10.58 | ||
| EV/EBITDA | 20.34 |
EPS(TTM)4.33
EY3.97%
EPS(NY)4.97
Fwd EY4.56%
FCF(TTM)3.38
FCFY3.1%
OCF(TTM)4.5
OCFY4.13%
SpS21.48
BVpS25.19
TBVpS10.31
PEG (NY)2.2
PEG (5Y)3.32
Graham Number49.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.64% | ||
| ROE | 27.65% | ||
| ROCE | 10.98% | ||
| ROIC | 9.43% | ||
| ROICexc | 10.51% | ||
| ROICexgc | 19.91% | ||
| OM | 17.97% | ||
| PM (TTM) | 32.43% | ||
| GM | 56.33% | ||
| FCFM | 15.72% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
ROICexc(3y)12.18%
ROICexc(5y)11.89%
ROICexgc(3y)32.65%
ROICexgc(5y)35.03%
ROCE(3y)12.16%
ROCE(5y)11.86%
ROICexgc growth 3Y-24.08%
ROICexgc growth 5Y-8.19%
ROICexc growth 3Y-10.71%
ROICexc growth 5Y6.04%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
F-Score7
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.98 | ||
| Debt/EBITDA | 1.19 | ||
| Cap/Depr | 72.02% | ||
| Cap/Sales | 5.25% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.01% | ||
| Profit Quality | 48.47% | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 5.65 |
F-Score7
WACC8.39%
ROIC/WACC1.12
Cap/Depr(3y)63.63%
Cap/Depr(5y)61.92%
Cap/Sales(3y)4.94%
Cap/Sales(5y)5.1%
Profit Quality(3y)82.78%
Profit Quality(5y)99.6%
High Growth Momentum
Growth
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
EPS Next Y11.44%
EPS Next 2Y10.84%
EPS Next 3Y10.85%
EPS Next 5Y9.87%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%
Revenue Next Year6.43%
Revenue Next 2Y7.1%
Revenue Next 3Y7.23%
Revenue Next 5Y7.13%
EBIT growth 1Y14.57%
EBIT growth 3Y-6.62%
EBIT growth 5Y8.41%
EBIT Next Year27.77%
EBIT Next 3Y15.64%
EBIT Next 5Y12.28%
FCF growth 1Y23.45%
FCF growth 3Y-9.78%
FCF growth 5Y7.14%
OCF growth 1Y21.27%
OCF growth 3Y-6.69%
OCF growth 5Y6.88%
ABBOTT LABORATORIES / ABL.DE FAQ
What is the fundamental rating for ABL stock?
ChartMill assigns a fundamental rating of 6 / 10 to ABL.DE.
What is the valuation status for ABL stock?
ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.
What is the profitability of ABL stock?
ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 8 / 10.
What are the PE and PB ratios of ABBOTT LABORATORIES (ABL.DE) stock?
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABL.DE) is 25.18 and the Price/Book (PB) ratio is 4.33.
Can you provide the financial health for ABL stock?
The financial health rating of ABBOTT LABORATORIES (ABL.DE) is 7 / 10.